Global Next Generation Sequencing Market 2021-2025

Global Next Generation Sequencing Market 2021-2025
Researcher has been monitoring the next generation sequencing market and it is poised to grow by $ 2.47 bn during 2021-2025, progressing at a CAGR of 11.77% during the forecast period. Our report on the next generation sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased utilization of next generation sequencing methods and growing demand for early diagnosis of genetic disorders. In addition, the increased utilization of next generation sequencing methods is anticipated to boost the growth of the market as well.
The next generation sequencing market analysis include Product and Geography segments.
Researcher's next generation sequencing market is segmented as below:
By Product
• Consumables
• Equipment
By Geographical Landscape
• North America
• Europe
• Asia
• ROW
This study identifies the availability of a wide range of next generation sequencing productsas one of the prime reasons driving the next generation sequencing market growth during the next few years.
Researcher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on next generation sequencing market covers the following areas:
• Next generation sequencing market sizing
• Next generation sequencing market forecast
• Next generation sequencing market industry analysis
Researcher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading next generation sequencing market vendors that include Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina Inc., Laboratory Corp. of America Holdings, Merck KGaA, PerkinElmer Inc., QIAGEN NV, Takara Bio Inc., and Thermo Fisher Scientific Inc. Also, the next generation sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Researcher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Researcher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
TNV-19820740

24-Dec-2021

120
License